Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping-Reference-Cited by-同舟云学术

Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping

Published:2021-02 Issue: Volume:218 Page:107689
ISSN:0163-7258
Container-title:Pharmacology & Therapeutics
language:en
Short-container-title:Pharmacology & Therapeutics

Author:

Miners John O.,Rowland Andrew,Novak Jonathan J.,Lapham Kimberly,Goosen Theunis C.

Funder

Pfizer Australia

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference345 articles.

1. Inhibition of UGT2B7 enzyme activity in human and rat liver microsomes by herbal constituents;Abdullah;Molecules,2018

2. The effect of ionized species on microsomal binding;Abraham;European Journal of Medicinal Chemistry,2012

3. Quantitative characterization of major hepatic UDP-glucuronosyltransferase enzymes in human liver microsomes: Comparison of two proteomic methods and correlation with catalytic activity;Achour;Drug Metabolism and Disposition,2017

4. Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5′-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics;Achour;Drug Metabolism and Disposition,2014

5. Selectivity for inhibition of nilotinib on the catalytic activity of human UDP-glucuronosyltransferases;Ai;Xenobiotica,2014

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTs;Pharmaceutical Research;2024-08

2. Self-modifying NanoEnhancers facilitating lysosomal escape for cGAS-STING cascading activation in tumor immunotherapy;Nano Today;2024-08

3. Beyond Cytotoxic Potency: Disposition Features Required to Design ADC Payload;Xenobiotica;2024-07-17

4. Mechanisms and emerging strategies for irinotecan-induced diarrhea;European Journal of Pharmacology;2024-07

5. Identification of Bromophenols' glucuronidation and its induction on UDP- glucuronosyltransferases isoforms;Ecotoxicology and Environmental Safety;2024-05